Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODD Regimen in Refractory Lymphoid Malignancies
NCT00837200Phase 2Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Mar 2009
- Primary completion
- Jan 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase in acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), multiple myeloma (MM), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Mar 2009; status: terminated.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)chronic lymphocytic leukemia (CLL)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00837200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837200.